New agents intended for use in treatment of anxiety, depression, etc., disclosed in recent patents Aug. 1, 2008
GSK's 5-HT6 receptor antagonist SB-742457 improves global function in mild-to-moderate AD Aug. 1, 2008
Novel GSK-3 inhibitor increases neuron survival and attenuates neuropathology in transgenic AD mice July 31, 2008
RSS